Gene · 1890
Papers4,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In vitro evaluation of Axitinib and Sorafenib treatment in glioblastoma cell viability and morphology. | Rom J Morphol Embryol | 2023 | 37518874 | PubTator, text mining | PubMed |
| Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral Heterogeneity. | Int J Mol Sci | 2023 | 37511126 | PubTator, text mining | PubMed |
| Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives. | J Clin Med | 2023 | 37510761 | PubTator, text mining | PubMed |
| A Clinical Qualification Protocol Highlights Overlapping Genomic Influences and Neuro-Autonomic Mechanisms in Ehlers-Danlos and Long COVID-19 Syndromes. | Curr Issues Mol Biol | 2023 | 37504295 | PubTator, text mining | PubMed |
| Identification of the key genes of tuberculosis and construction of a diagnostic model via weighted gene co-expression network analysis. | J Infect Chemother | 2023 | 37499902 | PubTator, text mining | PubMed |
| Inclusion body myositis with early onset: a population-based study. | J Neurol | 2023 | 37498322 | PubTator, text mining | PubMed |
| Case Report: Vision Loss Induced by Capecitabine in Patient with Preexisting Left Eyes Blind. | Case Rep Oncol | 2023 | 37497421 | PubTator, text mining | PubMed |
| A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease. | Nat Commun | 2023 | 37468493 | PubTator, text mining | PubMed |
| Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects. | Cancer Drug Resist | 2023 | 37457133 | PubTator, text mining | PubMed |
| Distinctive gastrointestinal motor dysfunction in patients with MNGIE. | Neurogastroenterol Motil | 2023 | 37448106 | PubTator, text mining | PubMed |
| Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study. | Cancers (Basel) | 2023 | 37444575 | PubTator, text mining | PubMed |
| State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine. | Cancers (Basel) | 2023 | 37444534 | PubTator, text mining | PubMed |
| Ribonucleotide synthesis by NME6 fuels mitochondrial gene expression. | EMBO J | 2023 | 37439264 | PubTator, text mining | PubMed |
| Dissecting the human gut microbiome to better decipher drug liability: A once-forgotten organ takes center stage. | J Adv Res | 2023 | 37419381 | PubTator, text mining | PubMed |
| Meta-Analysis of Capecitabine versus 5-Fluorouracil in Advanced Gastric Cancer. | Evid Based Complement Alternat Med | 2023 | 37408581 | PubTator, text mining | PubMed |
| Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer. | Front Oncol | 2023 | 37384288 | PubTator, text mining | PubMed |
| Drug-Induced Liver Injury Caused by Capecitabine: A Case Report and a Literature Review. | Case Rep Oncol | 2023 | 37384198 | PubTator, text mining | PubMed |
| Fulminant Neonatal Liver Failure in MPV 17-Related Mitochondrial DNA Depletion Syndrome. | Case Reports Hepatol | 2023 | 37384111 | PubTator, text mining | PubMed |
| Capecitabine May Accelerate Atherosclerosis and Causes Acute Myocardial Infarction in the Left Main Trunk. | Cureus | 2023 | 37378198 | PubTator, text mining | PubMed |
| Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting. | Pharmaceuticals (Basel) | 2023 | 37375753 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1890/papers?page=13